首页> 美国卫生研究院文献>Journal of Medical Genetics >Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression
【2h】

Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression

机译:RET原癌基因中的特定多态性在Hirschsprung病患者中过分表达可能代表修饰表型表达的基因座

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hirschsprung disease (HSCR) is a common genetic disorder presenting with functional intestinal obstruction secondary to enteric aganglionosis. HSCR can be familial or sporadic. Although five putative susceptibility genes have been identified, only germline mutations in the RET proto-oncogene account for a significant minority (up to 50%) of familial HSCR; 3% of sporadic HSCR in a population based series carry RET mutations. From 1998 to February 1999, we prospectively ascertained 64 cases of sporadic HSCR from the western Andalusia region. To determine if polymorphic sequence variants within RET could act as low penetrance predisposing alleles, we examined allelic frequencies at seven polymorphic loci in this population based series. Whether allele frequencies differed from those in the control population were determined by either chi-squared analysis or Fisher's exact test. For two sequence variants, A45A (c 135G→A) (exon 2) and L769L (c 2307T→G) (exon 13), the rarer polymorphic allele was over-represented among HSCR cases versus controls (p<0.0006). In contrast, two other polymorphisms, G691S (c 2071C→A) (exon 11) and S904S (c 2712C→G) (exon 15), were under-represented in the HSCR patients compared to controls (p=0.02). Polymorphisms in the RET proto-oncogene appear to predispose to HSCR in a complex, low penetrance fashion and may also modify phenotypic expression.


Keywords: polymorphism; low penetrance alleles; neurocristopathy; chromosome 10
机译:Hirschsprung病(HSCR)是一种常见的遗传性疾病,其表现为继发于肠神经节细胞增生症的功能性肠梗阻。 HSCR可以是家族性的或散发性的。尽管已经鉴定出五个推定的易感基因,但是仅RET原癌基因中的种系突变占家族性HSCR的显着少数(高达50%)。在基于人群的系列中,零星的HSCR携带RET突变。从1998年到1999年2月,我们前瞻性地确定了安达卢西亚西部地区散发的HSCR 64例。为了确定RET中的多态性序列变体是否可以作为低渗透性易感等位基因,我们研究了这个基于人口的系列中七个多态性基因座的等位基因频率。等位基因频率是否不同于对照组的等位基因频率是通过卡方分析或Fisher精确检验确定的。对于两个序列变体,A45A(c 135G→A)(外显子2)和L769L(c 2307T→G)(外显子13),在HSCR病例中相对于对照而言,罕见的多态性等位基因过表达(p <0.0006)。相反,与对照组相比,HSCR患者中的其他两个多态性,G691S(c 2071C→A)(外显子11)和S904S(c 2712C→G)(外显子15)的代表性不足。 RET原癌基因中的多态性似乎以一种复杂的,低渗透性的方式对HSCR易感,并且还可能改变表型的表达。


低外显率等位基因;神经病10号染色体

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号